Ann: Telix 2023 Full Year Results and Investor Webcast/Call, page-131

yesand i liken Zircaix to Illuccix in TAM terms, if not better no known competitor, and for how many years is Illuccix in a monopoly position in Kidney imaging ?if Telix trades on Illuccix value alone ( as per UBS report $13, or 6 or 7 times historical revenues).... then Zirciax which is anywhere between US$500-US$1B times the same, 6 or 7 times historical revenues, then Zircaix should create a further US$2B in enterprise value minimum. you can work out and play the max number or a further $13 minimum and its arguably 12 weeks away !!!! clinicians desperately waiting for it. unbelievable results in trials etc anyways, all this has been discussed many times here, so nothing new.